Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Cash from Operations (2022 - 2025)

Envoy Medical's Cash from Operations history spans 4 years, with the latest figure at 4331000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 65.12% year-over-year to 4331000.0; the TTM value through Sep 2025 reached 17607000.0, up 26.65%, while the annual FY2024 figure was 17949000.0, 5.02% down from the prior year.
  • Cash from Operations for Q3 2025 was 4331000.0 at Envoy Medical, up from 4460000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1099000.0 in Q3 2023 and bottomed at 11145000.0 in Q4 2023.
  • The 4-year median for Cash from Operations is 4034000.0 (2023), against an average of 3757400.0.
  • The largest YoY upside for Cash from Operations was 120.92% in 2023 against a maximum downside of 908.1% in 2023.
  • A 4-year view of Cash from Operations shows it stood at 2379000.0 in 2022, then crashed by 368.47% to 11145000.0 in 2023, then soared by 54.32% to 5091000.0 in 2024, then grew by 14.93% to 4331000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Cash from Operations are 4331000.0 (Q3 2025), 4460000.0 (Q2 2025), and 3725000.0 (Q1 2025).